- CEO
- Zhi Zhuang
- Full Time Employees
- 1,161
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Beijing China
- IPO Date
- Nov 1, 2022
- Business
- BMC Medical Co., Ltd. is a medical technology company that develops, manufactures, and commercializes medical devices, consumables, and digital health software for the diagnosis, treatment, and chronic management of sleep-disordered breathing and chronic respiratory diseases. Founded in 2001 and headquartered in Beijing, China, the company is publicly listed on the ChiNext board of the Shenzhen Stock Exchange under the ticker 301367. The company operates globally, supplying products and services to hospitals, sleep disorder centers, clinics, home medical equipment distributors, and individual patients in more than 100 countries and regions across North America, Europe, the Asia-Pacific, Latin America, and the Middle East.
The company's core business is organized into several comprehensive product and service categories: non-invasive ventilation devices, comprising continuous positive airway pressure (CPAP), auto-adjusting positive airway pressure (APAP), and bi-level positive airway pressure (BPAP) therapy devices marketed under the RESmart, G3, Luna, and M1 Mini series for the treatment of obstructive sleep apnea and chronic respiratory insufficiency; patient interfaces and consumables, comprising full-face masks, nasal masks, nasal pillows masks, and pediatric interfaces under the iVolve and N5/F5/P2 product series, as well as heated humidifiers, breathing circuits, replacement tubing, and air filters; respiratory therapy equipment, comprising high-flow nasal cannula (HFNC) oxygen therapy systems and stationary and portable medical oxygen concentrators for chronic obstructive pulmonary disease (COPD) management and acute institutional respiratory care; sleep diagnostic systems, comprising clinical multi-channel polysomnography (PSG) devices and portable sleep screening monitors under the PolyWatch series; and digital health and patient management solutions, comprising the proprietary PAP Link cloud-based platform available across web, desktop, and mobile applications for remote therapy data transmission, compliance monitoring, and clinical workflow management.
BMC Medical conducts its research, manufacturing, and supply chain operations through multiple specialized subsidiaries and operational centers, including major production and R&D facilities located in Beijing, Tianjin, and Dongguan. In recent corporate developments, the company enacted a strategic corporate restructuring and rebranding initiative, updating its Chinese corporate name to Beijing Remeite Medical Technology Co., Ltd. to align its corporate identity with its primary Remeite brand while maintaining BMC Medical Co., Ltd. as its global corporate name and 301367 as its exchange ticker. The company has also expanded its manufacturing scale and automated production lines across its Dongguan facility, accelerated the international rollout of its next-generation G3 smart ventilator series, and expanded its PAP Link ecosystem with upgraded tele-monitoring and cloud analytics capabilities. Furthermore, BMC Medical has reinforced its overseas distribution partnerships and regulatory clearance portfolio across North American and European healthcare markets following channel stabilization and inventory normalization in global home-care equipment channels.